BPC-157 dosage calculator.
Reconstitution math + body-weight-scaled reference doses from the published BPC-157 research literature. The two most-cited figures: 250 mcg/day and 500 mcg/day, with body-weight scaling at roughly 2.5 mcg/kg/day.
Calculator
U-100 INSULIN-SYRINGE BASISThe reference doses, sourced
3 PROTOCOL ANCHORSThe BPC-157 dosing literature is mostly animal studies extrapolated to human research protocols. The three figures most-cited:
- 250 mcg/day — lower-end research-protocol dose, cited in multiple gastrointestinal-injury and tendon-healing rodent studies extrapolated to human research.
- 500 mcg/day — upper-end research-protocol dose, sometimes split into two 250 mcg administrations per day.
- ~2.5 mcg/kg/day — body-weight-scaled reference, derived from the rodent-study dose ranges. For an 80 kg subject this rounds to roughly 200 mcg/day; for 100 kg, 250 mcg.
These figures are research-protocol references, not clinical dosing instructions. BPC-157 is not FDA-approved for any human indication. The studies that produced these dose ranges are preclinical or limited-protocol.
Why 5 mg vials are common
Vendor catalogs cluster heavily on 5 mg and 10 mg BPC-157 vials. At a 250 mcg daily reference dose, a 5 mg vial yields 20 doses; a 10 mg vial yields 40. The 5 mg / 2 mL reconstitution at 250 mcg dose is 10 IU on an insulin syringe — a measurable, clean dose-volume that landed as the de facto research-protocol standard.
Reconstitution specifics
BPC-157 is stable in bacteriostatic water at refrigerator temperature (2–8°C) for up to 30 days post-reconstitution. Freezing reconstituted material is generally not necessary at standard-volume vials. Protect from light.